Literature DB >> 9155851

Nebulisers for chronic obstructive pulmonary disease.

B R O'Driscoll1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9155851      PMCID： PMC1765875          DOI： 10.1136/thx.52.2008.s49

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  22 in total

1.  75 deaths in asthmatics prescribed home nebulisers.

Authors:  M R Sears; H H Rea; J Fenwick; A J Gillies; P E Holst; T V O'Donnell; R P Rothwell
Journal:  Br Med J (Clin Res Ed)       Date:  1987-02-21

2.  Emergency use of nebulised bronchodilator drugs in British hospitals.

Authors:  B R O'Driscoll; G M Cochrane
Journal:  Thorax       Date:  1987-07       Impact factor: 9.139

3.  Comparison of metered-dose inhaler attached to an Aerochamber with an updraft nebulizer for the administration of metaproterenol in hospitalized patients.

Authors:  M J Berenberg; W Baigelman; L A Cupples; L Pearce
Journal:  J Asthma       Date:  1985       Impact factor: 2.515

4.  Equivalence of continuous flow nebulizer and metered-dose inhaler with reservoir bag for treatment of acute airflow obstruction.

Authors:  J R Turner; K J Corkery; D Eckman; A M Gelb; A Lipavsky; D Sheppard
Journal:  Chest       Date:  1988-03       Impact factor: 9.410

5.  Use of nebulised saline and nebulised terbutaline as an adjunct to chest physiotherapy.

Authors:  P P Sutton; H G Gemmell; N Innes; J Davidson; F W Smith; J S Legge; J A Friend
Journal:  Thorax       Date:  1988-01       Impact factor: 9.139

6.  Cost-benefit comparison of aerosol bronchodilator delivery methods in hospitalized patients.

Authors:  A C Jasper; Z Mohsenifar; S Kahan; H S Goldberg; S K Koerner
Journal:  Chest       Date:  1987-04       Impact factor: 9.410

7.  Comparison of domiciliary nebulized salbutamol and salbutamol from a metered-dose inhaler in stable chronic airflow limitation.

Authors:  S C Jenkins; R W Heaton; T J Fulton; J Moxham
Journal:  Chest       Date:  1987-06       Impact factor: 9.410

8.  Comparison of nebulised salbutamol and ipratropium bromide with salbutamol alone in the treatment of chronic obstructive pulmonary disease.

Authors:  P Moayyedi; J Congleton; R L Page; S B Pearson; M F Muers
Journal:  Thorax       Date:  1995-08       Impact factor: 9.139

9.  Cumulative dose-response study comparing terbutaline pressurized aerosol administered via a pearshaped spacer and terbutaline in a nebulized solution.

Authors:  E B Madsen; A Bundgaard; K G Hidinger
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

10.  Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency room.

Authors:  A S Rebuck; K R Chapman; R Abboud; P D Pare; H Kreisman; N Wolkove; F Vickerson
Journal:  Am J Med       Date:  1987-01       Impact factor: 4.965
View more
  2 in total

1.  Intermediate care--Hospital-at-Home in chronic obstructive pulmonary disease: British Thoracic Society guideline.

Authors: 
Journal:  Thorax       Date:  2006-11-07       Impact factor: 9.139

2.  Is nebulized saline a placebo in COPD?

Authors:  Shahina Y Khan; B Ronan O'Driscoll
Journal:  BMC Pulm Med       Date:  2004-09-30       Impact factor: 3.317
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.